The natural successor to the DB11, the newcomer drops the cylinders and ups the power, maxing out at 325km/h.
3 min
Seeking to bridge the gap between supercars and grand tourers, Aston Martin has expanded the DB bloodline with the release of the DB12. Billed as the “world’s first Super Tourer”—debatable!—the new Aston Martin DB12 does away with the twin-turbo 5.2-litre V12 of its predecessor. Under the hood is a twin-turbo 4.0-litre V8 that delivers 500 kW of power and 800 Nm of torque — an increase of 53 kW and 100 Nm from the DB11.
All in all, that equates to the DB12 racing from 0-100km/h in 3.5 seconds with a top speed of 325km/h.
The V8 feeds power to the rear wheels through an eight-speed automatic transmission, with the addition of a new electronic limited-slip differential. Aston Martin claims its new rear differential “can go from fully open to 100% locked in a matter of milliseconds,” promoting more precise and consistent handling.
Under the skin, structural stiffness has been increased with the aluminium structure upping torsional stiffness by seven percent as a result of changes made to the engine cross brace, front and rear undertrays, front crossmember, and rear bulkhead. The resultant effect allows for gains in suspension performance as well as steering feel and overall driving pleasure.
The newcomer is unmistakable as anything other than an Aston Martin, with the low-and-wide proportions and two-door design a signature of the British marque. Taking on an athletic, aggressive stance, the Aston Martin DB12 is equipped with a more muscular physique befitting of its powertrain.
An upsized grille dominates the front end, which also sees the addition of a new lighting signature and surface detailing on the swept-back headlights and smaller frameless wing mirrors. On the nose sits the newly revised Aston Martin wings logo, with the DB12 the first production car to bear the badge. 21-inch alloys complement the wide design while optimising the aerodynamic profile of the vehicle.
Step inside and you’ll find an entirely redesigned interior. The newcomer does away with the Mercedes-Benz infotainment system of its predecessor. In its place is an in-house—a first for the marque—system with dual 10.25-inch screens and Aston Martin-designed switchgear. Rounding it out is surround sound audio designed by leading British auditory icon Bowers & Wilkins.
The cabin itself takes on an opulent tone, designed with long journeys in mind. There’s the option for full Bridge of Weir leather or Alcantara upholstery; each outfitted with a new quilting pattern introduced for the DB12.
The release of the Aston Martin DB12 coincides with the marque’s 110th anniversary, as well as 75 years of the DB line.
“The latest addition to Aston Martin’s most illustrious bloodline, DB12 exemplifies the brand by boldly moving forward,” says Marek Reichman, Chief Creative Officer of Aston Martin. “Emphatically fresh yet unmistakably Aston Martin, DB12 defines the new breed of Super Tourer.”
First deliveries are slated to begin in Q3, 2023. While Aston Martin is yet to release pricing, it’s a safe bet to assume it’ll be a step up from the DB11, which starts at $382,000 (before ORC).
As global demand for longevity treatments surges, Australia is fast becoming a player in this lucrative industry.
3 min
There was a time — not so long ago — when the idea of an indulgent spa day was simply about relaxing massages and therapeutic facials, followed by a five-star lunch and perhaps a dip in a mineral pool. But the health and wellness industry has evolved rapidly, bringing with it an explosion of cutting-edge treatments designed to slow ageing, boost vitality, and extend healthspan.
Cold-water plunge pools, infrared saunas, and float tanks have taken over as the staples of health spas, wellness centres, and high-end gyms. Even real estate developments are tapping into this trend. But now, high-tech longevity treatments — from cryotherapy and IV infusions to genetic testing and advanced cellular therapies — are taking the wellness scene in Australia to unprecedented levels.
A burgeoning market globally, the health and wellness industry is estimated to have been worth more than US$5.6 trillion in 2022. Projections suggest this figure will grow to a staggering $13 trillion by 2031, with Australia steadily catching up to the US and Europe, where longevity treatments are thriving. High-profile figures like Gwyneth Paltrow, Jennifer Aniston, Chris Hemsworth, and even Tom Brady are among the faces championing biohacking and experimental therapies, from stem cell infusions to blood transfusions.
The Rise of Longevity Clinics in Australia
One of the key players in Australia’s emerging longevity scene is Tristan Sternson, founder of Super Young. Sternson’s foray into the world of longevity treatments began as he approached 40 — a milestone that made him reflect on his health. As a former elite athlete, the transition from feeling invincible to feeling vulnerable led him to explore solutions that would help him reclaim vitality.
Initially frustrated by the lack of accessible health data locally, Sternson turned to overseas clinics for tests and treatments that painted a clearer picture of his biological needs. His experience inspired him to create Super Young, a Melbourne-based clinic offering evidence-based therapies tailored to individual needs. Services include cryotherapy, IV infusions, genetic testing, and biological age assessments. Memberships range from $85–$289 per week, while one-off tests start at $899.
Sternson emphasises the importance of personalised treatments. “I want people to start with the evidence side of it so they can really understand their own body and what treatments will work for them,” he says.
The Science of Longevity Medicine
Dr Karen Coates, an integrative medical doctor and a presenter for The Longevity Project at Gwinganna Lifestyle Retreat, echoes Sternson’s emphasis on personalisation. She explains that longevity isn’t just about living longer but about living better — optimising health today while securing vitality for the future.
“One-size-fits-all approaches don’t apply when it comes to longevity,” says Dr Coates. “It’s about understanding your body’s genetic makeup and adopting personalised strategies to support health and longevity.”
At Gwinganna’s four-night Longevity Project retreat, guests can undergo gene testing, biological age assessments, and learn strategies to bridge the gap between chronological and biological age. Packages for the retreat range from $2915 to $5460.
Biohacking for All Budgets
Not all longevity treatments come with hefty price tags. Health coach Camilla Thompson points out that simple lifestyle adjustments — like cold showers to stimulate circulation or adding Celtic sea salt to water for better hydration — can supplement advanced therapies.
While advanced treatments like stem cell and peptide therapies are yet to gain widespread regulatory approval in Australia, Sternson is optimistic about their future. He envisions a time when longevity centres will be as common as gyms, giving clients the tools to monitor and manage their health with precision.
“What I’d love to see is health insurance companies get on board,” Sternson adds. “If they can give discounts for safe driving based on car data, why not for healthy habits based on glucose monitoring or other health indicators?”
As Australia continues to embrace longevity medicine, it’s clear the industry is poised to reshape not just health and wellness but how Australians approach ageing itself.
